Maynard Um
-
-
-
-
-
-
-
LIXT exchanges preferred stock for common shares with Orbit Capital
-
-
-
-
-
-
-
LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)
-
-
-
-
-
-
-
Lixte Biotechnology Holdings, Inc. (LIXT) announces $1.05 million direct offering at $2.42 per share
-
-
-
-
-
404,866 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

